NIFTY 50▼21,833.20
-162.65 (-0.74%)
SENSEX▼71,901.99
-587.00 (-0.81%)
NIFTY BANK47,069.45
0.00 (0.00%)
TATA MOTORS▲977.55
6.20 (0.64%)
INDIAN RAILWAY FINANCE CORP▲142.10
0.15 (0.11%)
SUZLON ENERGY▲41.40
0.25 (0.61%)
TATA POWER▲432.75
3.00 (0.70%)
TATA STEEL▲161.20
1.15 (0.72%)
YES BANK▲23.95
0.05 (0.21%)
INDIAN RENEWABLE ENERGY▲163.30
0.15 (0.09%)
RELIANCE INDUSTRIES▼2,925.00
-3.65 (-0.12%)
RELIANCE POWER28.70
0.00 (0.00%)
HDFC BANK▲1,496.80
2.10 (0.14%)
RAIL VIKAS NIGAM▲260.55
0.65 (0.25%)
ADANI POWER▲600.15
2.05 (0.34%)
VODAFONE IDEA13.20
0.00 (0.00%)
JIO FIN SERVICES LTD▲379.95
1.55 (0.41%)
ZOMATO▼184.95
-0.25 (-0.13%)
NHPC▲89.65
0.15 (0.17%)
INDIAN RAILWAY TOURISM CORP▲998.50
5.55 (0.56%)
STATE BANK OF INDIA▲746.10
1.30 (0.17%)
INDIAN OIL CORP▲170.00
1.00 (0.59%)
MRF▼1,29,202.00
-29.50 (-0.02%)
ITC▲419.75
0.90 (0.21%)
ADANI GREEN ENERGY▲1,783.00
7.55 (0.43%)
ADANI ENTERPRISES▲3,035.00
15.70 (0.52%)
JAIPRAKASH POWER VENTURES▲17.35
0.15 (0.87%)
ADANI PORT & SEZ▲1,306.40
10.85 (0.84%)
Jubilant Pharmova Share Price
JUBLPHARMA
₹706.80+₹6.10 (0.87%) Past YearLast updated on 18 Apr, 2024 | 03:58 PM IST
₹--₹--
LH
What’s in news?
Company overview
About
Market cap
| Open₹708.25 | Close₹700.70 |
Circuit range₹840.80 - ₹560.60 | Day range₹-- - ₹-- | Year range₹299.05 - ₹724.40 |
Volume878 | Avg. traded₹-- | Revenue (12m)₹6,622 Cr |
Jubilant PharmovaJubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company's segments include Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six manufacturing facilities in India, United States and Canada and a network of approximately 48 radio pharmacies in the United States. The Contract Research and Development Services segment provides drug discovery and development services as well as clinical data software and service solutions. The Proprietary Novel Drugs segment is a patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.
Read more
Jubilant Pharmova Key indicators
52 week high₹724.40 | 52 week low₹299.05 | P/E ratio277.24 |
P/B ratio2.05 | ROE2.06% | ROCE3.67% |
Dividend yield0.74% | Debt/Equity ratio0.13 | EPS3.13 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 2 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin17.42% | Net profit margin6.16% |
ROE2.06% | ROA1.7% |
ROCE3.67% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Jubilant Pharmova Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Apr 18 2024 | ₹685.00 | ₹700.70 | |
Tue, Apr 16 2024 | ₹644.05 | ₹671.80 | |
Mon, Apr 15 2024 | ₹632.10 | ₹650.80 | |
Fri, Apr 12 2024 | ₹648.00 | ₹637.60 | -1.63% |
Wed, Apr 10 2024 | ₹653.90 | ₹649.35 | -0.70% |
Tue, Apr 9 2024 | ₹654.90 | ₹650.45 | -0.68% |
Mon, Apr 8 2024 | ₹647.90 | ₹653.15 | |
Fri, Apr 5 2024 | ₹633.85 | ₹644.55 |
Events
Corporate actions
Dividend • ₹5/share
Ex date 10 Aug 2023
Dividend • ₹5/share
Ex date 11 Aug 2022
Learn more